Importantly, as a clinical medicine for the treatment of diabetic peripheral neuropathy, clinical trials suggested that lipoic acid could reduce peripheral neuropathy pain intensity experienced by patients with type 2 diabetes mellitus and improve insulin sensitivity in prediabetic individuals (46–48). The gene discussed is INS; the disease is peripheral neuropathy.